Replies to post #341871 on Amarin Corp Plc (AMRN)

[rafunrafun]

on surveys only about one-third of doctors know about VASCEPA than even smaller percentage of patients. It is a promotion sensitive drug, it's not surprising that these awareness levels are that low because 2.5 months into the launch, it got truncated by COVID. So as COVID comes back, we will experiment with increasing our levels of promotion to try to grow it, but with an emphasis on maintaining profitability so that there, some of – and some promotion has longer lead items, better than others.

Some people would use COVID as a great opportunity to promote Vascepa, knowing well that COVID goes hand-in-hand with CVD and despite COVID, CVD still killed more Americans than COVID.

Others would blame COVID for their own failures.

We drew the latter.

[ralphey]

JUSt wondering .... did JT work as DIlbert in the past ?

[hayward]

ggwpa

Three paragraphs talking about generics GV market instead of saying. They can only produce so much due to their carvout and saying we are currently in a law suit concerning infringement !!! NEXT QUESTION PLEASE

Michael

[Birdbrain Ideas]

Thanks for posting this. I think Karim might be related to Ronald Reagan because he began three of his answers with "Well, ..."

Maybe we can blame the transcript, but I'm a little worried about Karim's communications skills after reading his words here and hearing a little from him around earnings time.

Communications __ getting its message across to doctors and patients in particular __ seems to be the main problem for Amarin. When Karim speaks, he seems very comfortable slipping into inside-baseball jargon. Little attention to plain language. Hopefully, his skill is in hiring the right people and making the right decisions about advertising, marketing and negotiating pricing in Europe.